The National Medical Research Center of Japan (NMRC) said its Covid-19 team had synthesized a special chemical that, when used in combination with the drug radecivir, can inhibit the reproduction of the virus.
In the future, if the specific drug of COVID-19 can be truly developed on this basis, it will be a good news for all mankind to fight against the epidemic and help all countries around the world to fight against the epidemic.

It is helpful to study Covid-19 specific drug

According to media reports, the team has previously produced more than 400 synthetic chemicals, and its focus has been on controlling specific proteases to prevent the virus from reproducing.
After a year-long study, the team finally identified two substances that can control the reproduction of Covid-19 virus.

One of them is a synthetic chemical that, when used in combination with the drug radecivir, can reduce the reproduction rate of the virus to one in 100 million.
However, the team has only developed the synthetic substance, but has not actually developed the Covid-19 magic bullet yet, which is still some time away.

Try to develop a specific medicine

Redecivir has been reported as a treatment for patients with COVID-19, but there is no clear evidence that it is an effective drug.
There is no real cure for CoviD-19, and people are still pinning their hopes on CoviD-19 vaccine.

In contrast to the race among pharmaceutical groups to develop a vaccine, the team had set their sights on a specific drug when they launched Covid-19 research in February last year.
In a series of studies, the team also found that Covid-19 propagates using a protease, which is essentially a catalyst, so the protease could be a key to stopping Covid-19 from propagating if the protease is eliminated in advance or if it is prevented from acting.

The epidemic situation in the world is critical

Although now many countries around the world have developed the COVID – 19 vaccines, including astrazeneca company, China national medicine group, the Chinese firm sinovac biological and other companies have successfully developed the COVID – 19 vaccine, countries around the world have begun vaccination work, but in fact only a few countries in the world can produce COVID – 19 vaccines, most countries there is no vaccine is available, the world health organization is to speed up vaccine procurement plan, is currently assessing the two vaccines.

Vaccination has not kept pace with the spread of Covid-19, which has now been diagnosed in more than 100 million people and is still rising.
It is also hoped that countries will be able to put aside ideological rivalries, provide vaccines as public health products for countries in need, and work together to combat the Covid-19 epidemic.